Cargando…

Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients

SIMPLE SUMMARY: Unlike the neutrophil/lymphocyte ratio (NLR), more complex complete blood count (CBC)-based systemic immune-inflammation cancer biomarkers have recently been proposed, such as the pan-immune-inflammation value (PIV). We aimed to assess both NLR and PIV in cutaneous melanoma (CM) pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gambichler, Thilo, Stang, Andreas, Mansour, Rita, Scheel, Christina H., Nick, Celine, Abu Rached, Nessr, Becker, Jürgen C., Susok, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496745/ https://www.ncbi.nlm.nih.gov/pubmed/36139570 http://dx.doi.org/10.3390/cancers14184410

Ejemplares similares

Model for End-Stage Liver Disease Correlates with Disease Relapse and Death of Patients with Merkel Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2023)

Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma
por: Gambichler, T., et al.
Publicado: (2022)

The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy
por: Susok, L., et al.
Publicado: (2022)

Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma
por: Susok, Laura, et al.
Publicado: (2021)

Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year Analysis
por: Susok, Laura, et al.
Publicado: (2021)

Expression of DNA mismatch repair proteins in melanoma patients treated with immune checkpoint inhibitors
por: Gambichler, T., et al.
Publicado: (2022)

Advances in Targeting Cutaneous Melanoma
por: Kasakovski, Dimitri, et al.
Publicado: (2021)

Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
por: Gambichler, Thilo, et al.
Publicado: (2020)

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy
por: Gambichler, Thilo, et al.
Publicado: (2018)

Evans’ syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma
por: Gambichler, Thilo, et al.
Publicado: (2022)

Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa—A Monocentric Study in Germany
por: Abu Rached, Nessr, et al.
Publicado: (2023)

The Antineoplastic Effect of Dimethyl Fumarate on Virus-Negative Merkel Cell Carcinoma Cell Lines: Preliminary Results
por: Gambichler, Thilo, et al.
Publicado: (2023)

The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results
por: Gambichler, Thilo, et al.
Publicado: (2023)

Expression of Mismatch Repair Proteins in Merkel Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2021)

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
por: Gambichler, Thilo, et al.
Publicado: (2017)

The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
por: Abu Rached, Nessr, et al.
Publicado: (2022)

Mismatch Repair Protein Expression and Microsatellite Instability in Cutaneous Squamous Cell Carcinoma
por: Gambichler, Thilo, et al.
Publicado: (2021)

Current Medical and Surgical Treatment of Hidradenitis Suppurativa—A Comprehensive Review
por: Ocker, Lennart, et al.
Publicado: (2022)

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022)

Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients
por: Gambichler, Thilo, et al.
Publicado: (2023)

Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes
por: Gambichler, Thilo, et al.
Publicado: (2022)

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
por: Ferrucci, P F, et al.
Publicado: (2015)

Multivariate analysis of prognostic factors in patients with nodular melanoma
por: Susok, L., et al.
Publicado: (2021)

Baseline Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study
por: Wade, Ryckie G., et al.
Publicado: (2018)

On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
por: Gambichler, Thilo, et al.
Publicado: (2020)

Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience
por: Gambichler, T., et al.
Publicado: (2021)

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
por: Peiffer, Lukas, et al.
Publicado: (2020)

Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma Skin Cancer, and Cutaneous Melanoma
por: El Abbadi, Sam, et al.
Publicado: (2021)

Correction to: Comparison of the Skin Cancer Quality of Life Impact Tool and the Skin Cancer Index Questionnaire in Measurement of Health-Related Quality of Life and the Effect of Patient Education Brochures in Patients with Actinic Keratosis, Non-melanoma Skin Cancer, and Cutaneous Melanoma
por: El Abbadi, Sam, et al.
Publicado: (2021)

Undifferentiated pleomorphic sarcoma of the breast with neoplastic fever: case report and genomic characterization
por: Gambichler, Thilo, et al.
Publicado: (2022)

Hypereosinophilic syndrome complicated by severe vascular damage and gangrene
por: Gambichler, Thilo, et al.
Publicado: (2019)

Protein expression of prognostic genes in primary melanoma and benign nevi
por: Gambichler, T., et al.
Publicado: (2021)

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
por: Capone, Mariaelena, et al.
Publicado: (2018)

Cold Plasma Therapy in Chronic Wounds—A Multicenter, Randomized Controlled Clinical Trial (Plasma on Chronic Wounds for Epidermal Regeneration Study): Preliminary Results
por: Abu Rached, Nessr, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma
por: Ma, Junjie, et al.
Publicado: (2018)

Association of Baseline Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics of Papillary Thyroid Carcinoma
por: Manatakis, Dimitrios K., et al.
Publicado: (2017)

Prognostic values of baseline cortisol levels and neutrophil to lymphocyte ratio in COVID-19
por: Erturk, Sengel Buket, et al.
Publicado: (2023)

Baseline neutrophil‐to‐lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling
por: Verma, Raj, et al.
Publicado: (2023)

Neutrophil to Lymphocyte Ratio (NLR) in captive chimpanzees (Pan troglodytes): The effects of sex, age, and rearing
por: Neal Webb, Sarah J., et al.
Publicado: (2020)

Baseline neutrophil–lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-small-cell lung cancer
por: Koh, Young Wha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_67phqhc0sgpbtvqvtarfaam1j1